Michael Dimeo

Michael DiMeo currently serves as the Chief Financial Officer at ExThera Medical, which specializes in developing extracorporeal blood filtration devices aimed at treating critically ill patients. Prior to this role, Michael held the position of Chief Financial Officer at Tastik Services and Vibalogics, where responsibilities focused on financial leadership within the bio-pharmaceutical sector, emphasizing customer-centric development and manufacturing services. As Director of Finance at Exosome Diagnostics, a subsidiary of Bio-Techne, Michael contributed to advancing biofluid-based diagnostics. Michael began an executive leadership role at CUSTOMatrix, Inc. before completing an MBA at the D'Amore-McKim School of Business at Northeastern University.